PL233902A1 - - Google Patents

Info

Publication number
PL233902A1
PL233902A1 PL23390281A PL23390281A PL233902A1 PL 233902 A1 PL233902 A1 PL 233902A1 PL 23390281 A PL23390281 A PL 23390281A PL 23390281 A PL23390281 A PL 23390281A PL 233902 A1 PL233902 A1 PL 233902A1
Authority
PL
Poland
Application number
PL23390281A
Other versions
PL131162B1 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL233902A1 publication Critical patent/PL233902A1/xx
Publication of PL131162B1 publication Critical patent/PL131162B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1981233902A 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one PL131162B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
PL233902A1 true PL233902A1 (enExample) 1982-07-19
PL131162B1 PL131162B1 (en) 1984-10-31

Family

ID=22465278

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one

Country Status (5)

Country Link
JP (1) JPS56150091A (enExample)
KR (2) KR850000412B1 (enExample)
PL (2) PL132428B1 (enExample)
SU (1) SU1093251A3 (enExample)
ZA (1) ZA812085B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
EP2252608A4 (en) 2008-02-29 2012-10-03 Vm Discovery Inc METHOD FOR TREATING PAIN SYNDROME AND OTHER SUFFERING
UA116981C2 (uk) * 2012-02-10 2018-06-11 ПіТіСі ТЕРАП'ЮТІКС, ІНК. Сполуки для лікування спінальної м'язової атрофії
EP3310169B1 (en) 2015-05-30 2023-05-17 PTC Therapeutics, Inc. Methods for modulating rna splicing
PL3386511T3 (pl) 2015-12-10 2021-11-08 Ptc Therapeutics, Inc. Sposoby leczenia choroby huntingtona
EP3544435A4 (en) 2016-11-28 2020-11-04 PTC Therapeutics, Inc. RNA SPLICE MODULATION PROCESSES
KR20200033249A (ko) 2017-06-05 2020-03-27 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
US11608501B2 (en) 2017-06-14 2023-03-21 Ptc Therapeutics, Inc. Methods for modifying RNA splicing
US11395822B2 (en) 2017-06-28 2022-07-26 Ptc Therapeutics, Inc. Methods for treating Huntington's disease
CN111182898B (zh) 2017-06-28 2024-04-16 Ptc医疗公司 用于治疗亨廷顿氏病的方法
EA202092001A1 (ru) 2018-03-27 2021-01-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни гентингтона
EP3814360B8 (en) 2018-06-27 2024-11-06 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
SG11202012674PA (en) 2018-06-27 2021-01-28 Ptc Therapeutics Inc Heterocyclic and heteroaryl compounds for treating huntington's disease
AU2019294482B2 (en) 2018-06-27 2022-09-01 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Also Published As

Publication number Publication date
PL230364A1 (enExample) 1982-03-29
PL131162B1 (en) 1984-10-31
KR830005220A (ko) 1983-08-03
JPH0215550B2 (enExample) 1990-04-12
KR850000412B1 (ko) 1985-03-26
ZA812085B (en) 1982-11-24
KR850000413B1 (ko) 1985-03-26
PL132428B1 (en) 1985-03-30
JPS56150091A (en) 1981-11-20
SU1093251A3 (ru) 1984-05-15

Similar Documents

Publication Publication Date Title
FR2495060B1 (enExample)
FR2496142B1 (enExample)
IN156553B (enExample)
FR2482286B1 (enExample)
GR75026B (enExample)
FR2491687B1 (enExample)
FR2493660B1 (enExample)
FR2497379B1 (enExample)
FR2484016B1 (enExample)
FR2491018B2 (enExample)
FR2477935B1 (enExample)
FR2485716B1 (enExample)
IN156029B (enExample)
FR2479459B1 (enExample)
GR75664B (enExample)
FR2483054B3 (enExample)
FR2490815B1 (enExample)
FR2478043B3 (enExample)
JPS56108262U (enExample)
JPS56140009U (enExample)
FR2488721B1 (enExample)
FR2491211B2 (enExample)
FR2478087B1 (enExample)
JPS56104971U (enExample)
JPS55164027U (enExample)